IP Verse

Use Of Ulipristal Acetate For Treating Uterine Fibroids - EP2684565

The patent EP2684565 was granted to Laboratoire HRA Pharma on Oct 2, 2019. The application was originally filed on Jan 28, 2009 under application number EP13187859A. The patent is currently recorded with a legal status of "Revoked".

EP2684565

LABORATOIRE HRA PHARMA
Application Number
EP13187859A
Filing Date
Jan 28, 2009
Status
Revoked
May 6, 2022
Publication Date
Oct 2, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (2)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

HOFFMANN EITLEJul 2, 2020HOFFMANN EITLEADMISSIBLE
WITTKOPPJul 2, 2020HAMM & WITTKOPPADMISSIBLE

Patent Citations (8) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONUS2005208129
DESCRIPTIONUS4954490
DESCRIPTIONUS5073548
DESCRIPTIONUS5929262
DESCRIPTIONWO2004065405
DESCRIPTIONWO2004078709
OPPOSITIONWO2009095418
SEARCHWO2007038796

Non-Patent Literature (NPL) Citations (18) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference Text
DESCRIPTION- ATTARDI ET AL., JOURNAL OF STEROID BIOCHEMISTRY & MOLECULAR BIOLOGY, (2004), vol. 88, pages 277 - 288
DESCRIPTION- BLITHE DL; NIEMAN LK; BLYE RP; STRATTON P; PASSARO M, STEROIDS, (2003), vol. 68, no. 10-13, pages 1013 - 7
DESCRIPTION- CRAMER SF; PATEL A, "The frequency of uterine leiomyomas", AM J CLIN PATHOL., (1990), vol. 94, no. 4, pages 435 - 8
DESCRIPTION- FARQUHAR CM; STEINER CA, "Hysterectomy rates in the United States 1990-1997", OBSTET GYNECOL., (2002), vol. 99, no. 2, pages 229 - 34
DESCRIPTION- LANGER, SCIENCE, (1990), vol. 249, pages 1527 - 1533
DESCRIPTION- SOMIGLIANA E; VERCELLINI P; DAGUATI R; PASIN R; DE GIORGI 0; CROSIGNANI PG, "Fibroids and female reproduction: a critical analysis of the evidence", HUM REPROD UPDATE, (2007), vol. 13, no. 5, pages 465 - 76
DESCRIPTION- ZENG C; GU M; HUANG H, "A clinical control study on the treatment of uterine leiomyoma with gonadotrophin releasing hormone agonist or mifepristone", ZHONGHUA FU CHAN KE ZA ZHI, (1998), vol. 33, no. 8, pages 490 - 2
DESCRIPTION- MURPHY AA; MORALES AJ; KETTEL LM; YEN SS, "Regression of uterine leiomyomata to the antiprogesterone RU486: dose-response effect", FERTIL STERIL., (1995), vol. 64, no. 1, doi:doi:10.1016/S0015-0282(16)57678-X, pages 187 - 90, XP029525166
DESCRIPTION- LANGER R, "New Methods of Drug Delivery", SCIENCE, (1990), vol. 249, doi:doi:10.1126/science.2218494, pages 1527 - 33, XP000169082
OPPOSITION- Hague W. M., Et Al, "Use of LHRH analogue to obtain reversible castration in a patient with benign metastasizing leiomyoma", British Journal of Obstetrics and Gynaecology, (19860501), vol. 93, pages 455 - 460, XP055772840
OPPOSITION- Orihuela Pedro A, "Drug evaluation: Ulipristal, a progesterone receptor antagonist as a contraceptive and for the treatment of uterine fibroids", CURRENT OPINION IN INVESTIGATIONAL DRUGS, US, (20071001), vol. 8, no. 10, ISSN 1472-4472, pages 859 - 866, XP009115744
OPPOSITION- Patton Kurt T, Et Al, "Benign metastasizing leiomyoma: clonality, telomere length and clinicopathologic analysis", Modern Pathology, (20060101), vol. 19, pages 130 - 140, XP055772836
OPPOSITION- Robboy Stanley J, Et Al, "Pathology and Pathophysiology of Uterine Smooth-Muscle Tumors", Environmental Health Perspectives, (20001001), vol. 108, pages 779 - 784, XP055772842
OPPOSITION- Schally Andrew, Comaru-Schally, A.M., "Mode of Action of LHRH Analogs", Holland-Frei Cancer Medicine, 6th Ed., BC Decker, (20030101), pages 1 - 3, XP055772834
OPPOSITION- Tavassoli F, Devilee, P., "Tumours of the Breast and Female Genital Organs", WHO Pathology & Genetics, (20030101), pages 239 - 242, XP055772846
OPPOSITION- Tietze, L. Gunther, K. Horbe, A. Pawlik, C. Klosterhalfen, B. Handt, S. Merkelbach-Bruse, S., "Benign metastasizing leiomyoma: A cytogenetically balanced but clonal disease", Human Pathology, US, (20000101), vol. 31, no. 1, ISSN 0046-8177, pages 126 - 128, XP005047638
OPPOSITION- Eric D Levens, "82 Ranomized, Placebo-controlled, Double Blind, Parallel Trial of the Novel Selective Progesterone Receptor Modulator, CDB-29-14", Reproductive Sciences Poster Sessions, doi:10.1177/193371910701400101, (20070101), pages 79A - 80A, Reproductive Sciences Poster Sessions, (20180803), XP055497228
SEARCH- ORIHUELA PEDRO A, "Ulipristal, a progesterone receptor antagonist as a contraceptive and for the treatment of uterine fibroids", CURRENT OPINION IN INVESTIGATIONAL DRUGS, PHARMAPRESS, US, (20071001), vol. 8, no. 10, ISSN 1472-4472, pages 859 - 866, XP009115744 [I] 1-14 * the whole document *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents